Special reports and reviewsNitric oxide in gastrointestinal health and disease
Section snippets
Biology of nNOS
The most prominent role of nNOS-derived NO in GI motility is as an inhibitory nonadrenergic noncholinergic (NANC)10, 11 smooth muscle cell relaxant via nNOS-derived activation of smooth muscle cell guanylate cyclase. Nerves throughout the length of the luminal GI tract express nNOS with highest levels in the pyloric sphincter,12 particularly the soma and processes of myenteric nerves.13 Although initial reports of nNOS were specific to neurons,13 evidence is emerging that nNOS is widely
Biology of eNOS
eNOS is the key NOS isoform responsible for NO-regulated vasodilation in the GI system. Thus it follows that in the GI system, eNOS expression is most prominent in endothelial cells lining vascular channels,throughout the gut, liver, and pancreas, including arterial, venous, and microcirculatory vessels.54 eNOS may also be expressed in gut smooth muscle cells and ICC.55, 56 eNOS-derived NO is produced under basal conditions and in response to a variety of stimuli. For example, a number of
Mesenteric ischemia-reperfusion injury
NO inhibits the adhesion and activation of specific hematopoietic cells, thereby acting as a mitigating force against vascular stasis and ensuing ischemic tissue injury. Cells most prominently involved in this process and inhibited by NO include leukocytes and platelets. In the case of leukocyte function, NO inhibits leukocyte adhesion to the vascular endothelium, in part through inhibiting the ability of leukocytes to roll along the vascular channels, a prerequisite step for adhesion.89 The
Biology of iNOS
iNOS is the NOS isoform most broadly implicated in the processes of inflammation and carcinogenesis in the GI system. iNOS expression can be detected within almost any GI cell type, given the appropriate stimulatory milieu, though most notably in inflammatory cells. Some reports also suggest constitutive expression in the epithelia of the normal human colon102 and myenteric neurons.55 iNOS is regulated predominantly at the transcriptional level through mechanisms dependent on NF-κB.103 However,
Summary
NO is implicated in multiple important processes in gastrohepatic biology and diseases, and the pathogenic role of NO in these processes remains an area of active investigation. Interestingly, some disease conditions are associated with excess NO generation; other disease conditions, such as achalasia, are associated with deficient NO generation, while in some syndromes, such as portal hypertension and liver injury, both deficiencies and excesses of NO generation appear to contribute, with the
References (131)
- et al.
Role of nitric oxide in gastrointestinal and hepatic function and disease
Gastroenterology
(1992) - et al.
Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase
J Biol Chem
(1992) - et al.
Guanylate cyclase and the NO/cGMP signaling pathway
Biochim Biophys Acta
(1999) - et al.
Nitrosylationthe prototypic redox-based signaling mechanism
Cell
(2001) - et al.
Nitric oxide mediates inhibitory nerve input in human and canine jejunum
Gastroenterology
(1993) - et al.
Distinct expression of splice variants of neuronal nitric oxide synthase in the human gastrointestinal tract
Gastroenterology
(2000) - et al.
The effects of recombinant human hemoglobin on esophageal motor functions in humans
Gastroenterology
(1995) - et al.
Lower esophageal sphincter is achalasic in nNOS(−/−) and hypotensive in W/W(v) mutant mice
Gastroenterology
(2001) - et al.
Isosorbide dinitrate and nifedipine treatment of achalasiaa clinical, manometric and radionuclide evaluation
Gastroenterology
(1982) - et al.
Hypertrophic pyloric stenosisultrastructural abnormalities of enteric nerves and the interstitial cells of Cajal
J Pediatr Surg
(1995)